GENERAL SECRETARIAT
LEADERSHIP
ORGANIZATIONAL STRUCTURE
PRESS RELEASES
CONTACT
PRIVATE INVESTMENTS
DEVELOPMENT LAW
GENERAL INFORMATION
FRAMEWORK
CALLS FOR INVESTORS
EVALUATION GUIDES
AUDIT GUIDES
EVALUATION BODIES
AUDIT BODIES
SUPPORTING MATERIAL
COMPETENT AGENTS
INTEGRATED INFORMATION SYSTEM
FOREIGN DIRECT INVESTMENTS
GENERAL INFORMATION
FRAMEWORK DEPARTMENT Α'
FRAMEWORK DEPARTMENT Β'
SUPPORTING MATERIAL DEPARTMENT Α'
SUPPORTING MATERIAL DEPARTMENT Β'
STATE AID INFORMATION SYSTEM
NEWS
CLASSIFICATION TABLE
MISCELLANEOUS
STRATEGIC INVESTMENTS
DIRECTORATE
GENERAL INFORMATION
FRAMEWORK
CATEGORIES & INCENTIVES
INVESTMENT PROJECTS
SUPPORTING MATERIAL
CONSULTATIONS
NEWS
el
GENERAL SECRETARIAT
LEADERSHIP
ORGANIZATIONAL STRUCTURE
PRESS RELEASES
CONTACT
PRIVATE INVESTMENTS
STRATEGIC INVESTMENTS
el
DEVELOPMENT LAW
GENERAL INFORMATION
FRAMEWORK
CALLS FOR INVESTORS
EVALUATION GUIDES
AUDIT GUIDES
EVALUATION BODIES
AUDIT BODIES
SUPPORTING MATERIAL
COMPETENT AGENTS
DEVELOPMENT LAWS INFORMATION SYSTEMS
FOREIGN DIRECT INVESTMENTS
GENERAL INFORMATION
FRAMEWORK DEPARTMENT Α'
FRAMEWORK DEPARTMENT Β'
SUPPORTING MATERIAL DEPARTMENT Α'
SUPPORTING MATERIAL DEPARTMENT Β'
STATE AID INFORMATION SYSTEM
NEWS
CLASSIFICATION TABLE
MISCELLANEOUS
DIRECTORATE
GENERAL INFORMATION
FRAMEWORK
CATEGORIES & INCENTIVES
INVESTMENT PROJECTS
SUPPORTING MATERIAL
CONSULTATIONS
NEWS
Projects in sector:
Research and Development
Select sector
Projects of Common Interest
Mines
Energy
PPPs
Industrial Waste Management
Telecommunications
Residential Development
Tourism
Data Centers
Research and Development
Industry
Shopping Centers
Select region
Attica
Central Greece
Central Macedonia
Crete
Eastern Macedonia and Thrace
Epirus
Ionian Islands
North Aegean
Peloponnese
South Aegean
Thessaly
Western Greece
Western Macedonia
Expansion of the Capacity of an Industrial Unit for the Production of Paper Products
Central Greece / Research and Development
Industrial Research and Development of a Monoclonal Antibody with code DM-02 as a Biological Therapy for the Treatment of Malignant Neoplasms within the Modern Regulatory Framework
Attica / Research and Development
Industrial Research and Development of a Monoclonal Antibody with code DM-01 as a Biological Therapy for the Treatment of Malignant Neoplasms within the Modern Regulatory Framework
Attica / Research and Development
Personalized Cell & Gene near-Greek Patient Therapies (POCare Model) - THERACELL LABORATORIES PCC
Peloponnese / Research and Development
ELPEN S.A. - Research Development - Factory Construction - Experimental Laboratory Construction
Attica / Research and Development
Cookie Consent by
Free Privacy Policy website
Please ensure Javascript is enabled for purposes of
website accessibility
